| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 07/18/2002 | WO2002055013A2 Therapeutic chromone compounds |
| 07/18/2002 | WO2002055012A2 Therapeutic heterocyclic compounds |
| 07/18/2002 | WO2002028418B1 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| 07/18/2002 | WO2002024661A3 New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 07/18/2002 | WO2002022558A3 2-amino-2-alkyl-3 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 07/18/2002 | WO2002020481A3 Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine |
| 07/18/2002 | WO2002016310A9 Selective androgen receptor modulators and methods of use thereof |
| 07/18/2002 | WO2002006242A3 5-substituted 2-aryl-4-pyrimidinones |
| 07/18/2002 | WO2002002633A3 Transporters and ion channels |
| 07/18/2002 | WO2001094391A3 Intracellular signaling proteins |
| 07/18/2002 | WO2001094345A3 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
| 07/18/2002 | WO2001085783A3 Nucleic acids encoding polypeptides related to the alpha subunit of the glycoprotein hormone family and methods of use thereof |
| 07/18/2002 | WO2001083480A3 Dihydropyridine compounds and methods of use |
| 07/18/2002 | WO2001079282A3 Molecules associated with human reproduction |
| 07/18/2002 | WO2001066747A3 Proteins named fctrx and nucleic acids encoding same |
| 07/18/2002 | WO2001039766A3 Screening invertebrate pheromones for therapeutic activity |
| 07/18/2002 | US20020094328 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 07/18/2002 | DE10064312A1 Cholinpyruvat, Verfahren zu dessen Herstellung, Cholinpyruvat enthaltende Formulierung sowie deren Verwendung Choline pyruvate, containing process for the production thereof, choline pyruvate formulation and the use thereof |
| 07/18/2002 | CA2434274A1 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them |
| 07/18/2002 | CA2434152A1 Therapeutic heterocyclic compounds |
| 07/18/2002 | CA2433950A1 Therapeutic chromone compounds |
| 07/18/2002 | CA2433656A1 Hormone replacement therapy method and its administration form |
| 07/18/2002 | CA2430588A1 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors |
| 07/17/2002 | EP1223170A1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof |
| 07/17/2002 | EP1222683A1 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 07/17/2002 | EP1222459A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 07/17/2002 | EP1222253A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 07/17/2002 | EP1222200A1 Vaccine |
| 07/17/2002 | EP1222190A1 5-(2-substituted-5-heterocyclylsulphonylpyrid-3-yl)-dihydropyrazolo[4,3-d]pyrimidin-7-ones as phosphodiesterase inhibitors |
| 07/17/2002 | EP1222183A1 Benzopyran derivatives |
| 07/17/2002 | EP1221955A2 Immunostimulatory nucleic acids |
| 07/17/2002 | EP1042353B1 17beta-aryl (arylmethyl) oxy(thio)alkyl -androstane derivatives |
| 07/17/2002 | EP0888298B1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 07/17/2002 | EP0804219B1 Inhibin compositions and methods of use thereof |
| 07/17/2002 | CN1359300A Uro-genital condition treatment system |
| 07/17/2002 | CN1358528A Pill for nourishing yin and tonifying kidney |
| 07/17/2002 | CN1358497A Sperm-killing father and mother network degradable micro emulsion and preparation process |
| 07/16/2002 | US6420567 Prodrugs |
| 07/16/2002 | US6420525 Human transcription factor ZGCL-1 |
| 07/16/2002 | US6420383 Calcium channel blockers, hypersensitivity, allergy, asthma, bronchospasm, dysmenorrhea, esophageal spasm, glaucoma, premature labor, urinary tract disorders, gastrointestinal motility disorders and cardiovascular disorders. |
| 07/16/2002 | US6420368 Thienopyrimidines |
| 07/16/2002 | US6420342 Ribose, folic acid, orotic acid |
| 07/16/2002 | US6420157 Expression vector coding enzymatic polypeptide for use in the treatment of inflammation and sexual disorders; for use in laundry detergents |
| 07/16/2002 | US6420150 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 07/11/2002 | WO2002054064A2 Method for screening for progesterone receptor isoform-specific ligands |
| 07/11/2002 | WO2002053558A1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 07/11/2002 | WO2002053557A1 Novel sulfamides and their use as endothelin receptor antagonists |
| 07/11/2002 | WO2002053522A2 Novel estrogen receptor ligands and methods i |
| 07/11/2002 | WO2002053168A2 Sterilising pill |
| 07/11/2002 | WO2002053140A2 New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents |
| 07/11/2002 | WO2002053137A2 Pharmaceutical composition for treatment of phimosis using topical corticosteroid |
| 07/11/2002 | WO2002018348A3 Quinazoline derivatives as alpha-1 adrenergic antagonists |
| 07/11/2002 | WO2002017914A8 Fused pyrrolocarbazoles against inflammation |
| 07/11/2002 | WO2002010199A3 C3b/c4b complement receptor-like molecules and uses thereof |
| 07/11/2002 | WO2001096311A3 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases |
| 07/11/2002 | WO2001046443A3 Proteases |
| 07/11/2002 | WO2001044473A3 Polypeptides and nucleic acids encoding same |
| 07/11/2002 | WO2001043540A3 Methods for producing transgenic animals |
| 07/11/2002 | US20020091272 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 07/11/2002 | US20020091270 Sulfonamides containing oxazole and substituted thiophene rings, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure |
| 07/11/2002 | US20020091266 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 07/11/2002 | US20020091121 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 07/11/2002 | US20020091088 Administration of at least one agent at a level which enhances NO and which does not appreciably alter normal systemic vascular tone |
| 07/11/2002 | US20020091084 Human calcineurin B-like protein (CAB) and polynucleotides which identify and encode CAB. |
| 07/11/2002 | US20020090695 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 07/11/2002 | US20020090373 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof |
| 07/11/2002 | US20020090368 Therapeutic uses of bactericidal/permeability increasing (BPI) protein products |
| 07/11/2002 | US20020090365 For therapy of vaginal and gastrointestinal infections |
| 07/11/2002 | CA2433828A1 Novel estrogen receptor ligands and methods i |
| 07/11/2002 | CA2431041A1 New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents |
| 07/10/2002 | EP1221440A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
| 07/10/2002 | EP1221439A1 Tetrahydroquinoline derivatives |
| 07/10/2002 | EP1220947A2 50 human secreted proteins |
| 07/10/2002 | EP1220932A1 Human carboxypeptidases and polynucleotides encoding the same |
| 07/10/2002 | EP1220918A2 Hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use |
| 07/10/2002 | EP1220865A1 43 human secreted proteins |
| 07/10/2002 | EP1220863A1 Purine derivatives |
| 07/10/2002 | EP1220862A1 Purine derivatives |
| 07/10/2002 | EP1220857A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/10/2002 | EP1220856A2 Pyrazolo[4,3-d]pyrimidine derivatives |
| 07/10/2002 | EP1220855A2 Anhydrous salt |
| 07/10/2002 | EP1220831A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 07/10/2002 | EP1220675A2 Hormone-sensitive lipase activity mediated male infertility |
| 07/10/2002 | EP1220667A2 Treating endometriosis or infertility, or improving fertility |
| 07/10/2002 | EP1220666A2 Methods for modulating the human sexual response |
| 07/10/2002 | EP1071446B1 Regulation of ovarian maturation and function using epidermal growth factor |
| 07/10/2002 | EP0914158B1 Pharmaceutical combination containing a compound having angiotensin ii antagonistic activity and a compound which increases the insulin-sensitivity |
| 07/10/2002 | EP0812319B1 2-arylbenzazole compounds |
| 07/10/2002 | CN1358193A Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy |
| 07/10/2002 | CN1358192A 嘌呤衍生物 Purine derivatives |
| 07/10/2002 | CN1358178A Pharmaceutical compounds |
| 07/10/2002 | CN1358104A Low dose estrogen interupted hormone replacement therapy |
| 07/10/2002 | CN1357373A Oral capsule for treating condyloma acuminata |
| 07/10/2002 | CN1357352A Prepn for treating hyperprolatin |
| 07/10/2002 | CN1357337A Prepn of Xianjia medicine granule for treating hyperprolactin |
| 07/10/2002 | CN1087344C Transforming growth factor alpha-H1 |
| 07/10/2002 | CN1087170C Medical composition for prevention of early pregnancy |
| 07/09/2002 | US6417334 Antagonists to chaperonin 10 |
| 07/09/2002 | US6417237 Macromolecular drug complexes and compositions containing the same |
| 07/09/2002 | US6417218 Substituted imidazoles, their preparation and use |